Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

The relational association between multiple sexual partners and HIV testing on cervical cancer screening among women of reproductive age in Ghana: A national population-based study

  • Agani Afaya,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

    Affiliation Department of Nursing, School of Nursing and Midwifery, University of Health and Allied Sciences, Ho, Ghana

    ⨯
  • Wise Awunyo ,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Writing – original draft, Writing – review & editing

    wiseawunyo38@gmail.com

    Affiliations Department of Nursing, School of Nursing and Midwifery, University of Health and Allied Sciences, Ho, Ghana, Department of Surgery, Surgical Sub-BMC, Ho Teaching Hospital, Volta Region, Ghana

    ⨯
  • Mary Adaeze Udeoha,

    Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

    Affiliation Department of Nursing, School of Nursing and Midwifery, University of Health and Allied Sciences, Ho, Ghana

    ⨯
  • Matilda Mawusi Kodjo,

    Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

    Affiliation Department of Nursing, School of Nursing and Midwifery, University of Health and Allied Sciences, Ho, Ghana

    ⨯
  • Maxwell Tii Kumbeni

    Roles Conceptualization, Investigation, Methodology, Supervision, Validation, Writing – original draft, Writing – review & editing

    Affiliation Medicaid Policy and Fee-for-Service Operations, Medicaid Division, Oregon Health Authority, Salem, United States of America

    ⨯

Abstract

Background

Cervical cancer screening remains vital in the early detection of precancerous lesions and promotes better treatment outcomes. Though evidence suggested multiple sexual partners and HIV infection as risk factors for cervical cancer, limited studies have investigated how multiple sexual partners and HIV infection impact cervical cancer screening in Ghana. Therefore, this study assessed the association of multiple sexual partnership and HIV testing on cervical cancer screening among Ghanaian women of reproductive age.

Methods

The study utilized data from the 2022 Ghana Demographic and Health Survey. A weighted representative sample of 15,014 women from the 16 regions of Ghana was used for the analysis. Descriptive statistics, Pearson’s Chi-square and multivariable logistic regressions were used to analyze the data. Adjusted odds ratios (aORs) at 95% Confidence Intervals were presented from the multivariable logistic regression.

Results

The prevalence of cervical cancer screening was 5.0%. We found lower odds of cervical cancer screening with multiple sexual partners at the bivariate level [aOR=0.69, 95% CI: 0.52–0.90], but no association was found in the multivariable model. On the other hand, women who had ever tested for HIV [aOR=4.73, 95% CI:3.39–6.59] were more likely to screen for cervical cancer than those who had never tested. This was still significant after adjusting for covariates [aOR=2.47, 95% CI:1.61–3.80].

Conclusions

The study highlights the influence of multiple sexual partners and HIV testing on cervical cancer screening uptake among women of reproductive age in Ghana. Though the study found no significant association between multiple sexual partners and cervical screening uptake, HIV testing was a predictor of cervical cancer screening among women in Ghana. We recommend continued creation of awareness of cervical cancer screening among women of reproductive age.

Citation: Afaya A, Awunyo W, Udeoha MA, Kodjo MM, Kumbeni MT (2026) The relational association between multiple sexual partners and HIV testing on cervical cancer screening among women of reproductive age in Ghana: A national population-based study. PLoS One 21(3): e0344086. https://doi.org/10.1371/journal.pone.0344086

Editor: Minal Dakhave, Dognosis India Private Limited, INDIA

Received: July 22, 2025; Accepted: February 16, 2026; Published: March 16, 2026

Copyright: © 2026 Afaya et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: The dataset (Ghana Demographic and Health Survey, 2022) used for the study is publicly available at the Measure DHS repository (https://dhsprogram.com/data/dataset/Ghana_Standard-DHS_2022.cfm?flag=1), and the report is available at https://dhsprogram.com/pubs/pdf/FR387/FR387.pdf.

Funding: The author(s) received no specific funding for this work.

Competing interests: The authors have declared that no competing interests exist.

Abbreviations: aOR, Adjusted Odds Ratio; CI, Confidence Interval; cOR, Crude Odds Ratio; HDI, Human Development Index; HIV, Human Immunodeficiency Virus; HPV, Human Papilloma Virus; ICF, International Coaching Federation; KOICA, Korean International Cooperation Agency; LMICs, Low, and Middle, Income Countries; LMICs, Lower, and Middle, Income Countries; PCA, Principal Component Analysis; PMI, President’s Malaria Initiative; PPS, Probability Proportional to Size; SSA, sub, Saharan Africa; UK AID, United Kingdom Agency for International Development; UNFPA, United Nations Population Fund; UNICEF, United Nations International Children’s Fund; USAID, United States Agency for International Development; VIF, Variance Inflation Factors; WHO, World Health Organization

Background

Cervical cancer continues to be a significant public health concern worldwide, particularly in low- and middle-income countries (LMICs) [1,2]. Globally, cervical cancer is the fourth most common cancer in women, accounting for about 660,000 new cases and around 350,000 deaths in 2022, with 94% of these deaths occurring in LMICs [3–5]. Cervical cancer incidence and death rates show significant regional variations. Countries with a low Human Development Index (HDI) have incidence rates twice as high as mortality rates, five times higher than in high HDI countries [4,6,7]. It is predicted that the worldwide burden of cervical cancer may increase to 760,082 new cases and 411,035 deaths by 2030, reflecting a 14.8% increase in cases and a 17.8% increase in deaths [8]. The World Health Organization (WHO) indicated that cervical cancer is largely preventable, but poor access to prevention and screening leads to 90% of deaths [9].

In sub-Saharan Africa (SSA), cervical cancer is the most frequent disease among women, accounting for 22.2% of all malignancies and ranking as the main cause of cancer-related deaths in the region [10]. In 2022, among the top 20 countries with the highest cervical cancer burden, 18 of them were in SSA. These countries accounted for 23% of total cervical cancer mortality. Additionally, 85% of patients presented at late stages of the disease [3,11] and this proportion has increased over the last two decades, with large annual increases observed in Malawi (7.9%) and Uganda (2.2%) [12]. In 2023, an estimated 3,072 new cases of cervical cancer reported in Ghana, resulting in an age-standardized incidence rate of 27 per 100,000 women. In the same year, an estimated 1,815 women died from the condition, resulting in an age-standardized death rate of 16.9 per 100,000 women. It is anticipated that without any intervention, a total of 329,925 women in Ghana would die from the disease during 2020–2070, rising to 1,144,566 by 2120 [13].

Screening is a vital component in preventing cervical cancer. Beginning at age 30, Human Papillomavirus [14] DNA testing is the main screening technique, according to the WHO’s current screening recommendations [1,3]. The standard schedule for cervical cancer is every five to ten years for women of 30 and above till the age of 50 [15]. However, for HIV-positive women, screening should begin at age 25 and be done every three to five years [3,16]. Although cervical cancer screening has been identified to curb the menace, it is challenging, especially in low-resource settings [17]. In 2020, the WHO developed a global strategy to accelerate the elimination of cervical cancer. The WHO’s global strategy 90-70-90 aims to achieve 90% of girls vaccinated against HPV, 70% of women in the world screened using the HPV test, and 90% of women with cervical cancer should receive treatment appropriately by 2030 [18–23]. Countries will be regarded to have eradicated cervical cancer as a public health hazard when rates of new cases fall to 4 per 100,000 women-years. Modelling indicated that if these objectives are attained in 78 LMICs, cervical cancer will be eradicated in all LMICs, and a total of 74.1 million cancer cases and 62.6 million deaths would be prevented over the course of a century [13].

In Ghana, studies have already found low cervical cancer screening among women. A recent study in Ghana found that 7.27% of women aged 30–49 get screened for cervical cancer, with notable geographical differences; screening rates were lower for women in rural areas than for those in urban areas [24,25]. The high incidence of cervical cancer in several countries, including Ghana, is associated with a poor screening service use rate, which calls for focused initiatives to increase screening uptake and lessen the disease’s effects [25,26]. The following screening methods are available: visual inspection with VIA and Enhanced Visual Assessment (EVA) mobile colposcopy; cytology (Pap) testing, and HPV DNA testing, but women had to pay out of pocket [27]. Ghana launched the HPV vaccine in October 2025. The Ghana Health Services, in collaboration with Vaccine Alliance (Gavi), WHO, and UNICEF, launched the country’s first nationwide HPV vaccination campaign. The five-day campaign was expected to reach 2.4 million girls aged 9–14 years, both in and out of school, providing life-saving protection against cervical cancer [28].

Studies have found that HIV testing and having multiple sexual partners influenced cervical cancer screening [29–31]. However, in the Ghanaian context, there are limited studies that examine the interplay between multiple sexual partners and HIV testing on cervical cancer screening uptake. Existing studies in Ghana [32–36] have typically examined either sexual risk behaviours or HIV testing in isolation, therefore it is imperative to examine the influence of multiple sexual partners and HIV testing on cervical cancer screening uptake among women of reproductive age in Ghana.

Materials and methods

Data sources

The Ghana Statistical Service (GSS) conducted the 2022 Ghana Demographic and Health Survey (GDHS), which provided the data utilized in this study. Between October 17, 2022, and January 14, 2023, data were gathered. For the Demographic and Health Survey Program (DHS), GSS got technical support from the International Coaching Federation (ICF) to ensure that the survey procedures followed ethical research standards. The survey was funded by World Bank, The Global Fund, Korean International Cooperation Agency (KOICA), WHO, Government of Ghana, etc. Using data from the 2021 Population and Housing Census, Ghana Statistical Service adjusted the sample frame for the 2022 GDHS. Stratified two-stage cluster sampling was the sampling strategy employed in the 2022 GDHS. It was intended to produce representative findings for each of the 16 regions, for urban and rural areas, and at the national level. Using a probability proportional to size (PPS) approach, 618 target clusters were chosen for each region’s urban and rural regions in the first stage. Following that, a systematic random selection of the clusters selected in the first phase was used to choose the target number of clusters with equal probability for both urban and rural regions in each region. The second step was listing and updating the households in each cluster. A sample of households was selected from this list. With assistance from ICF, 30 randomly selected households from each cluster were interviewed. A nationwide stratified representative sample of 18,450 households was included in the 2022 GDHS, from which 15,014 women of reproductive age (15–49 years) were interviewed.

Measurements

Outcome variable.

The outcome variable was cervical cancer screening. Eligible women, that is, women between 15–49 years old were asked, “Have you ever been examined for cervical cancer by a health worker?” The responses were categorized as “0” for “No” and “1” for “Yes”.

Explanatory variables.

HIV testing and multiple sexual partnership were the explanatory variables. The questions posed to women for HIV testing were “Have you ever been tested for HIV? The responses were coded “0” for “No” and “1” for “Yes”. Multiple sexual partnerships were derived by asking women the number of sex partners excluding spouse in the last 12 months. The response was recoded as “0” = “No” and having one or more partners other than the spouse as “1” = “Yes”.

Covariates.

The study included ten covariates based on an extensive literature review and their availability in the data set [25,26,29,37–44]. The following covariates were included in the analysis: age was recoded (15–24, 25–34, 35–49), educational level (no education, primary education, secondary education, higher education), wealth index (poorest, poorer, middle, richer, richest), distance from health facility (big problem, not a big problem), frequency of reading newspaper or magazine (not at all, less than once a week, at least once a week), frequency of listening to radio (not at all, less than once a week, at least once a week), frequency of watching television (not at all, less than once a week, at least once a week), parity (0, 1–3, 4 and above), smokes cigarettes (no, yes), STI status (no, yes).

Statistical analysis

The study utilized Stata version 14.0 to analyze data employing both descriptive and inferential statistics. Person’s Chi-square test was used to determine whether there were any significant differences in cervical cancer screening uptake between the explanatory variables and covariates. Multivariable logistic regression analysis was used to examine the factors associated with cervical cancer uptake among women of reproductive age in Ghana. The multivariable logistics regression analyses consisted of two models. In model I, we adjusted for multiple sexual partnerships and HIV testing, and in the final model, we adjusted for other covariates. The data used for the analyses were weighted (v005/1000000) to account for the complex sampling of the survey. The results were reported as adjusted odds ratios (aOR) with their confidence intervals (CI) and statistical significance at p-value <0.05. A multicollinearity diagnostic test was performed to assess the variance inflation factors (VIF) for the variables that could account for cervical cancer screening (Min = 1.00, Mean VIF = 1.51, Max = 2.70). The rule of thumb was applied, where none of the variables had a higher VIF than required for exclusion in the multivariate analysis. All statistically significant variables were included in the final multivariate logistic regression analysis model.

Ethical consideration

This study did not require ethical approval because we used secondary data from DHS, which sought ethical approval from the Ghana Nutrition and Health Research Institute (GNHRI) Review Board and the National Research Ethics Review Committee (NRERC) at the Ministry of Health before the data were collected. Informed consent was sought and obtained from all participants. Parental or guardian consent was sought for individuals below 18 years during the survey. The dataset is publicly available at the Measure DHS repository (https://dhsprogram.com/data/dataset/Ghana_Standard-DHS_2022.cfm?flag=1), and the report is available at https://dhsprogram.com/pubs/pdf/FR387/FR387.pdf.

Results

Participants sociodemographic characteristics

A total of 15,014 women of reproductive age were included in the study. From Table 1, the majority (35.8%) of women were in the 15–24 year age group, had secondary education (59.9%), and resided in the urban areas (57.0%). Approximately twenty-three percentage belonged to richer households, 77.7% reported that distance to a health facility was not a major problem, and 88.5% had never read a newspaper or magazine. However, 42.3% had listened to radio at least once a week, and 61.6% had watched television at least once a week. Most (41.2%) of women had 1–3 children, 77.0% did not have multiple sexual partners, 99.1% did not smoke cigarettes, 94.5% had never had any STI in the last 12 months, and 57.3% had ever tested for HIV.

thumbnail
Download:
Table 1. Demographic characteristics of respondents on cervical cancer screening.

https://doi.org/10.1371/journal.pone.0344086.t001

Bivariate analysis of factors associated with cervical cancer screening

From the Chi-square analysis, women’s age, educational status, type of residence, household wealth status, distance to health facility, frequency of reading newspaper or magazine, frequency of listening to radio, frequency of watching television, parity, HIV testing and multiple sexual partners were significantly associated with cervical cancer screening (see Table 1).

Prevalence of cervical cancer screening

Fig 1 shows that only 5.0% [4.4–5.6] of women of reproductive age had ever screened for cervical cancer.

thumbnail
Download:
Fig 1. Prevalence of Cervical Cancer Screening among Women.

https://doi.org/10.1371/journal.pone.0344086.g001

Relational association between multiple sexual partners and HIV testing on cervical cancer screening

Table 2 presents the association between multiple sexual partners and HIV testing on cervical cancer screening uptake. The results show that women with multiple sexual partners [cOR=0.69, 95% CI: 0.52–0.90] were less likely to screen for cervical cancer compared to those who do not have multiple sexual partners in the unadjusted model (model I). However, there was no association between multiple sexual partners and cervical cancer screening in the adjusted model (model II). Also, in model I, women who had ever tested for HIV [cOR=4.73, 95% CI:3.39–6.59] were more likely to screen for cervical cancer than those who had never tested. This was still significant after adjusting for covariates [aOR=2.47, 95% CI:1.61–3.80] in model II. With regard to the covariates, the probability of cervical cancer screening was higher among women aged 25−34 [aOR=2.10, 95% CI:1.47–3.00] and 35−49 years [aOR=3.17, 95% CI:2.16–4.66] than those aged 15−24 years. Also, women with higher level of education [aOR=2.99, 95% CI:1.75–5.10] were more likely to screen for cervical cancer than those with no form of education. Moreover, women who belonged to the middle [aOR=1.87, 95% CI:1.05–3.30] and the richest household wealth quintiles [aOR=1.90, 95% CI:1.08–3.35] were more likely to have cervical cancer screening. Furthermore, women who read newspaper or magazine less than once a week [aOR=1.47, 95% CI:1.07–2.01] were more likely to have cervical cancer screening than those who did not read at all. Lastly, women who listened to radio at least once a week [aOR=1.31, 95% CI:1.02–1.68] also had higher odds of cervical cancer screening than those who did not listen to radio.

thumbnail
Download:
Table 2. The relational association of multiple sexual partners and HIV testing on cervical cancer screening.

https://doi.org/10.1371/journal.pone.0344086.t002

Discussion

This study sought to examine the association between having multiple sexual partners, HIV testing, and cervical cancer screening uptake among women of reproductive age in Ghana. We found no association between having multiple sexual partners and cervical cancer screening; however, HIV testing was associated with higher odds of cervical cancer screening among women. We also observed higher odds of cervical cancer screening with increasing age, education, household wealth, and media exposure.

Contrary to previous evidence indicating a significant positive relationship between having multiple sexual partners and cervical cancer screening [29,44,45], our study found no such association. One possible reason could be that women who have sex with more than one partner may not think they are more likely to have cervical cancer, which might make them less motivated to seek cervical cancer screening [34]. Also, not knowing much about the relationship between high-risk sexual conduct and cervical cancer, together with the social stigma around both sexual behavior and reproductive health services, may make people less likely to seek health care. Additionally, the findings may be a result of structural barriers, such as limited access to screening services, lack of education on cervical cancer, and the cost of the service [34]. Our findings underscore the need for comprehensive public health interventions that integrate cervical cancer education into sexual and reproductive health programs, especially those targeting high-risk populations. The lack of a correlation between multiple sexual partners and cervical cancer screening in this study may indicate a confluence of cultural, behavioral, and structural influences. Cultural norms that inhibit candid discourse on sexual conduct may result in the underreporting of sexual partners, obscuring any genuine relationship. The limited understanding of the connection between sexual risk behaviors and cervical cancer suggests that sexual history may not significantly impact screening choices. Instead, women’s screening habits are frequently influenced by factors such as fear, misunderstandings, low perceived vulnerability, and general health-seeking tendencies. Also, structural barriers such as access to screening services and cost further overshadow the individual behavioral influences [34].

Furthermore, the study found that women who had HIV testing were more likely to screen for cervical cancer. Our findings support the hypothesis that there is a significant association between HIV testing and cervical cancer screening uptake. One possible explanation is that HIV testing typically happens in healthcare institutions that simultaneously offer or encourage other preventative treatments, such as cervical cancer screening [46]. Women who have HIV tests may be more health-conscious or already involved with the healthcare system, which makes them more likely to hear about or be referred for cervical cancer screening. Our findings highlight the need for the integration of cervical cancer screening services into the routine HIV care as a gateway to broaden preventive health behaviors [47].

We found that increasing age was a predictor of cervical cancer screening uptake. Women aged between 35–49 years were more likely to screen for cervical cancer. This is in line with earlier studies that indicated that as women grow older, they tend to screen for cervical cancer [36,48–50]. This could be attributed to the fact that cervical cancer awareness is targeted towards older women and hence increasing its uptake compared to the younger ones, who do not benefit from these campaign activities [3]. Also, with increasing age, women become aware of the increased risk of certain diseases, including cervical cancer, which prompts them to screen for cervical cancer [3]. Consistent with previous studies [25,34,36,50–52], this study found that women with a higher level of education were more likely to screen for cervical cancer. A plausible explanation could be that educated women may be more exposed to and understand health information, including the relevance of screening for cervical cancer [53–56].

Also, our study found that women who belonged to the richest household wealth quintile were more likely to screen for cervical cancer. This is consistent with previous studies [25,29,57] which found a significant association between wealth and cervical cancer screening uptake. A possible explanation could be that wealthy women may be able to afford screening-related costs, such as transportation fares, the cost of screening, and related costs [57,58]. Lastly, mass media was found to be significantly associated with the uptake of cervical cancer, where women who listened to the radio at least once a week and read newspapers or magazines were more likely to screen for cervical cancer. This resonates with earlier studies that indicated a positive correlation between mass media exposure and cervical cancer screening [25]. This could be that relevant health information is published in newspapers or magazines or broadcast via the radio, which increases the knowledge and awareness for the prevention of cervical cancer screening [59].

Policy implications

To increase cervical cancer screening uptake, several targeted interventions should be considered among women of reproductive age. The integration of cervical cancer screening with HIV services can thereby simplify access, reduce missed opportunities, and enable women already in contact with the HIV care system to be screened during routine visits. Health education programs in schools for adolescents and young women could help to promote early concept familiarity on cervical carcinoma, HPV diagnosis, and regular screening. Furthermore, mobile screening clinics, allow services to reach underprivileged and hard-to-access communities, which in turn eliminates geographic and financial barriers. These interventions, in conjunction with community health worker outreach, culturally appropriate education, and improved referral systems, will lead to a substantial increase in screening uptake and overall cervical cancer prevention for women.

Strengths and limitations

The findings may be generalized to the larger population of Ghanaian women of reproductive age, given the use of a nationally representative dataset. The study’s strength stems from its originality as the first to investigate the relationship between multiple sexual partners and HIV testing on cervical screening uptake in Ghana. However, the study has limitations. First, variables used in the study were all self-reported, potentially introducing recall and social desirability biases. However, we do not expect systematic differences in recall and social biases for sexual behavior and HIV testing among the study participants. Second, the use of a cross-sectional design cannot infer causality. Lastly, though WHO recommends screening for cervical cancer at age 25, especially with individuals with HIV, the study included participants aged 15–24 years old. The findings may have been affected by potential misclassification arising from stigma-related underreporting of sexual behaviors, as well as the inclusion of participants aged 15–24 years who fall below the recommended age for cervical cancer screening.”

Conclusion

Despite the strong evidence that cervical cancer can be prevented by early screening to detect precancerous lesions, the utilization of cervical cancer screening tests remains low in Ghana. Though the study found no significant association between multiple sexual partnership and cervical screening uptake, HIV testing was a predictor of cervical cancer screening among women in Ghana. Therefore, public health initiatives are encouraged to educate all women, regardless of their sexual behavior and HIV status, on the significance of cervical cancer screening. This may promote the uptake of cervical cancer screening among women in Ghana.

Supporting information

S1 File. A forest plot for multivariate result.

https://doi.org/10.1371/journal.pone.0344086.s001

(DOCX)

References

  1. 1. Rayner M, Welp A, Stoler MH, Cantrell LA. Cervical Cancer Screening Recommendations: Now and for the Future. Healthcare (Basel). 2023;11(16):2273. pmid:37628471
  2. 2. Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L PM, Znaor A S, oerjomataram I, Bray: Global Cancer Observatory. 2024:https://gco.iarc.who.int/media/globocan/factsheets/populations/288-ghana-fact-sheet.pdf
  3. 3. World Health Organization: Cervical cancer. 2024:https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
  4. 4. Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2023;11(2):e197–206. pmid:36528031
  5. 5. Reichheld A, Mukherjee PK, Rahman SM, David KV, Pricilla RA. Prevalence of Cervical Cancer Screening and Awareness among Women in an Urban Community in South India-A Cross Sectional Study. Ann Glob Health. 2020;86(1):30. pmid:32211300
  6. 6. Pervaiz R, Faisal F. Cancer incidence and mortality are associated with human development index and health setups in Africa. J Egypt Natl Canc Inst. 2017;29(3):123–6. pmid:28669451
  7. 7. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63. pmid:38572751
  8. 8. Zhou L, Li Y, Wang H, Qin R, Han Z, Li R. Global cervical cancer elimination: quantifying the status, progress, and gaps. BMC Med. 2025;23(1):67. pmid:39901174
  9. 9. Dzinamarira T, Moyo E, Dzobo M, Mbunge E, Murewanhema G. Cervical cancer in sub-Saharan Africa: an urgent call for improving accessibility and use of preventive services. Int J Gynecol Cancer. 2023;33(4):592–7. pmid:36368710
  10. 10. Li Z, Liu P, Yin A, Zhang B, Xu J, Chen Z, et al. Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: The urgent need to address inequalities in cervical cancer. Int J Cancer. 2025;157(2):288–97. pmid:40026066
  11. 11. World Health Organization: Status of the Cervical Cancer Elimination Initiative in WHO African Region. 2022:https://www.afro.who.int/publications/status-cervical-cancer-elimination-initiative-who-african-region
  12. 12. Jedy-Agba E, Joko WY, Liu B, Buziba NG, Borok M, Korir A, et al. Trends in cervical cancer incidence in sub-Saharan Africa. Br J Cancer. 2020;123(1):148–54. pmid:32336751
  13. 13. Global Cancer Observatory: Elimination Planning Tool: Advancing towards cervical screening elimination, Ghana: International Agency for Research on Cancer: World Health Organization 2025, https://gco.iarc.fr/media/elimination_tool/factsheets/288-GHA-ghana.pdf
  14. 14. ICO/IARC HPV Information Centre: Ghana: Human Papillomavirus and Related Cancers, Fact Sheet 2023. 2023:https://hpvcentre.net/statistics/reports/GHA_FS.pdf
  15. 15. National Cancer Institute: Cervical Cancer Screening. 2025:https://www.cancer.gov/types/cervical/screening
  16. 16. Zegeye FR, Legasu TD, Bayou FD, Ali MA. Uptake of cervical cancer screening and associated factors among HIV positive women attending adult art clinic at public hospitals in Addis Ababa, Ethiopia, 2022. BMC Womens Health. 2024;24(1):377. pmid:38943118
  17. 17. Gupta R, Gupta S, Mehrotra R, Sodhani P. Cervical Cancer Screening in Resource-Constrained Countries: Current Status and Future Directions. Asian Pac J Cancer Prev. 2017;18(6):1461–7. pmid:28669152
  18. 18. Torode J, Kithaka B, Chowdhury R, Simelela N, Cruz JL, Tsu VD. National action towards a world free of cervical cancer for all women. Prev Med. 2021;144:106313. pmid:33678227
  19. 19. Gultekin M, Ramirez PT, Broutet N, Hutubessy R. World Health Organization call for action to eliminate cervical cancer globally. Int J Gynecol Cancer. 2020;30(4):426–7. pmid:32122950
  20. 20. Zou Z, Fairley CK, Ong JJ, Shen M, Chow EPF, Liu H, et al. Impact of achieving WHO’s 90-70-90 targets on cervical cancer elimination and potential benefits in preventing other HPV-related cancers in China: a modelling study. EClinicalMedicine. 2024;77:102878. pmid:39763509
  21. 21. World Health Organization: Global strategy to accelerate the elimination of cervical cancer as a public health problem. 2020:https://www.who.int/publications/i/item/9789240014107
  22. 22. Suba EJ, Donnelly AD, Duong DV, Gonzalez Mena LE, Neethling GS, Thai NV. WHO should adjust its global strategy for cervical cancer prevention. BMJ Glob Health. 2023;8(6):e012031. pmid:37308263
  23. 23. Kundrod KA, Jeronimo J, Vetter B, Maza M, Murenzi G, Phoolcharoen N, et al. Toward 70% cervical cancer screening coverage: Technical challenges and opportunities to increase access to human papillomavirus (HPV) testing. PLOS Glob Public Health. 2023;3(8):e0001982. pmid:37585432
  24. 24. Alpar AD, Ndiaye C, Guillaume D, Limaye RJ, Rosen JG. High unmet needs for cervical cancer screening among women living with HIV in six African countries: A population-based study. Int J STD AIDS. 2025;36(5):397–405. pmid:39835785
  25. 25. Adzigbli LA, Aboagye RG, Adeleye K, Osborne A, Ahinkorah BO. Cervical cancer screening uptake and its predictors among women aged 30-49 in Ghana: Providing evidence to support the World Health Organization’s cervical cancer elimination initiative. BMC Infect Dis. 2025;25(1):246. pmid:39984848
  26. 26. Appiah RS, Boakye K, Appiah G, Aidoo AA, Acquah-Hagan G, Singh B, et al. Rural-urban variations in cervical cancer screening uptake among women in Ghana: Evidence from the 2022 Ghana Demographic and Health Survey. BMC Womens Health. 2025;25(1):255. pmid:40420073
  27. 27. Effah K, Allotey J, Tekpor E, Wormenor CM, Amuah JE, Antwi-Boasiako E, et al. Nationwide cervical precancer screening in Ghana: concurrent HPV DNA testing and visual inspection under an expanded hub-and-spoke model. Sci Rep. 2025;15(1):1744. pmid:39799219
  28. 28. Vaccine Allience: Ghana launches HPV vaccine to protect over 2 million girls and combat cervical cancer. 2025, https://www.gavi.org/news/media-room/ghana-launches-hpv-vaccine-protect-over-2-million-girls-and-combat-cervical-cancer#:~:text=Back%20to-,Ghana%20launches%20HPV%20vaccine%20to%20protect%20over%202%20million%20girls,no%20girl%20is%20left%20behind
  29. 29. Okyere J. Multiple sexual partnership as an independent predictor of cervical cancer screening among women of reproductive age: an analysis of the 2022 Kenya demographic and health survey. BMC Cancer. 2025;25(1):259. pmid:39953452
  30. 30. Enyan NIE, Ken-Amoah S, Tuoyire DA, Akakpo KP, Agyare E, Obiri-Yeboah D. HIV status and knowledge of cervical cancer among women in Ghana. BMC Womens Health. 2024;24(1):112. pmid:38347531
  31. 31. Tchounga B, Boni SP, Koffi JJ, Horo AG, Tanon A, Messou E, et al. Cervical cancer screening uptake and correlates among HIV-infected women: a cross-sectional survey in Côte d’Ivoire, West Africa. BMJ Open. 2019;9(8):e029882. pmid:31473620
  32. 32. Saaka SA, Antabe R, Luginaah I. Correlates of HIV testing among men in Ghana: Cross-sectional analysis of the 2022 demographic and health survey. Int J STD AIDS. 2025;36(6):487–97. pmid:40022599
  33. 33. Akweh TY, Boakye BAJ, Adoku E, Teyko F, Tarkang EE. HIV testing uptake and its associated factors among Ghanaian men: insights from the 2022 Ghana demographic and health survey using the Anderson behavioral model. Discov Public Health. 2025;22(1).
  34. 34. Abubakari A-K, Gross J, Kwaku ID, Boateng IK. Factors Influencing Cervical Cancer Screening: A Cross-Sectional Study Among Ethnically Diverse Women in the Kumasi Metropolis of Ghana. Health Sci Rep. 2025;8(2):e70433. pmid:39949523
  35. 35. Tetteh J, Ntumy MY, Asamoah IE, Ekem-Ferguson G, Swaray SM, Yamson P, et al. Risky Sexual Behavior and HIV Infection Among Ghanaians Aged 15–49: Evidence From the Ghana Demographic Health Survey 2003 and 2014. Journal of Psychosexual Health. 2024;6(3):265–73.
  36. 36. Anaba EA, Alor SK, Badzi CD, Mbuwir CB, Muki B, Afaya A. Drivers of breast cancer and cervical cancer screening among women of reproductive age: insights from the Ghana Demographic and Health Survey. BMC Cancer. 2024;24(1):920. pmid:39080553
  37. 37. Kangmennaang J, Onyango EO, Luginaah I, Elliott SJ. The next Sub Saharan African epidemic? A case study of the determinants of cervical cancer knowledge and screening in Kenya. Soc Sci Med. 2018;197:203–12. pmid:29253722
  38. 38. Ng’ang’a A, Nyangasi M, Nkonge NG, Gathitu E, Kibachio J, Gichangi P, et al. Predictors of cervical cancer screening among Kenyan women: results of a nested case-control study in a nationally representative survey. BMC Public Health. 2018;18(Suppl 3):1221. pmid:30400916
  39. 39. Oketch SY, Kwena Z, Choi Y, Adewumi K, Moghadassi M, Bukusi EA, et al. Perspectives of women participating in a cervical cancer screening campaign with community-based HPV self-sampling in rural western Kenya: a qualitative study. BMC Womens Health. 2019;19(1):75. pmid:31196175
  40. 40. Dickson KS, Boateng ENK, Acquah E, Ayebeng C, Addo IY. Screening for cervical cancer among women in five countries in sub-saharan Africa: analysis of the role played by distance to health facility and socio-demographic factors. BMC Health Serv Res. 2023;23(1):61. pmid:36670402
  41. 41. Kessler TA. Cervical Cancer: Prevention and Early Detection. Semin Oncol Nurs. 2017;33(2):172–83. pmid:28343836
  42. 42. Okyere J, Aboagye RG, Seidu A-A, Asare BY-A, Mwamba B, Ahinkorah BO. Towards a cervical cancer-free future: women’s healthcare decision making and cervical cancer screening uptake in sub-Saharan Africa. BMJ Open. 2022;12(7):e058026. pmid:35906053
  43. 43. Tiruneh FN, Chuang K-Y, Ntenda PAM, Chuang Y-C. Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey. BMC Womens Health. 2017;17(1):109. pmid:29141612
  44. 44. Visanuyothin S, Chompikul J, Mongkolchati A. Determinants of cervical cancer screening adherence in urban areas of Nakhon Ratchasima Province, Thailand. J Infect Public Health. 2015;8(6):543–52. pmid:25975994
  45. 45. Fentie AM, Tadesse TB, Gebretekle GB. Factors affecting cervical cancer screening uptake, visual inspection with acetic acid positivity and its predictors among women attending cervical cancer screening service in Addis Ababa, Ethiopia. BMC Womens Health. 2020;20(1):147. pmid:32677933
  46. 46. Sigfrid L, Murphy G, Haldane V, Chuah FLH, Ong SE, Cervero-Liceras F, et al. Integrating cervical cancer with HIV healthcare services: A systematic review. PLoS One. 2017;12(7):e0181156. pmid:28732037
  47. 47. Mandiwa C, Sanna M, Gao W. Cervical cancer screening uptake among women living with HIV in the era of universal test and treat policy in Malawi: results from the 2020-2021 Malawi population-based HIV impact assessment. BMC Cancer. 2025;25(1):1052. pmid:40597781
  48. 48. Alie MS, Negesse Y, Ayenew M. Determinants of Cervical Cancer Screening Among Women Aged 30-49 Years Old in Four African Countries: A Cross-Sectional Secondary Data Analysis. Cancer Control. 2023;30:10732748231195681. pmid:37656980
  49. 49. Asgedom YS, Hailegebireal AH, Woldegeorgis BZ, Koyira MM, Seifu BL, Fente BM, et al. Towards 90-70-90 targets: Individual and community level factors associated with cervical cancer screening among women of reproductive age in Tanzania: A multi-level analysis based on 2022 Tanzania demographic and health survey. PLoS One. 2024;19(12):e0315438. pmid:39693312
  50. 50. Myint WW, Aggad R, Fan Q, Mendez SE. Factors Influencing Cervical Cancer Screening Uptake among Reproductive-Aged Filipino Women: Findings from the 2022 Philippines National Demographic and Health Survey. Womens Health Rep (New Rochelle). 2024;5(1):485–94. pmid:39035148
  51. 51. Isabirye A. Individual and intimate-partner factors associated with cervical cancer screening in Central Uganda. PLoS One. 2022;17(9):e0274602. pmid:36108074
  52. 52. Maheshwari V, Girotra S, Malik M, Basu S. Prevalence and predictors of cervical cancer screening among married women in India: A cross-sectional analysis of National Family Health Survey-5 data. Cancer Research, Statistics, and Treatment. 2025;8(1):30–8.
  53. 53. Soofi M, Karami-Matin B, Najafi F, Naghshbandi P, Soltani S. Decomposing socioeconomic disparity in the utilization of screening mammography: A cross-sectional analysis from the RaNCD cohort study. Health Care Women Int. 2023;44(9):1092–105. pmid:34982660
  54. 54. Nyaaba JA, Akurugu E. Knowledge, barriers and uptake towards Cervical Cancer screening among female health workers in Ghana: A perspective of the Health Belief Model. International Journal of Africa Nursing Sciences. 2023;19:100587.
  55. 55. Dickson KS, Boateng ENK, Acquah E, Ayebeng C, Addo IY. Screening for cervical cancer among women in five countries in sub-saharan Africa: analysis of the role played by distance to health facility and socio-demographic factors. BMC Health Serv Res. 2023;23(1):61. pmid:36670402
  56. 56. Ebu NI, Amissah-Essel S, Asiedu C, Akaba S, Pereko KA. Impact of health education intervention on knowledge and perception of cervical cancer and screening for women in Ghana. BMC Public Health. 2019;19(1):1505. pmid:31711469
  57. 57. Okyere J, Duodu PA, Aduse-Poku L, Agbadi P, Nutor JJ. Cervical cancer screening prevalence and its correlates in Cameroon: secondary data analysis of the 2018 demographic and health surveys. BMC Public Health. 2021;21(1):1071. pmid:34090372
  58. 58. Saaka SA, Hambali M-G. Factors associated with cervical cancer screening among women of reproductive age in Ghana. BMC Womens Health. 2024;24(1):519. pmid:39289681
  59. 59. Bawuah A, Wang VQ, Adeleye K, Ameyaw EK, Yaya S. Mass Media Exposure and Cervical Cancer Screening in Rural Sub-Saharan Africa: A Multi-Country Cross-Sectional Analysis. Health Sci Rep. 2025;8(4):e70663. pmid:40242257